Welch W J, Brown C R
Department of Medicine, University of California-SF, School of Medicine 94143-0854, USA.
Cell Stress Chaperones. 1996 Jun;1(2):109-15. doi: 10.1379/1466-1268(1996)001<0109:iomacc>2.3.co;2.
Protein folding inside the cell involves the participation of accessory components known as molecular chaperones. In addition to their active participation in the folding process, molecular chaperones serve as a type of 'quality control system', recognizing, retaining and targeting misfolded proteins for their eventual degradation. It is now known that a number of human diseases arise as a consequence of specific point mutations or deletions within genes encoding essential proteins. In many cases these mutations/deletions are not so severe as to totally destroy the biological activity of the particular gene product. Rather, the mutations often result in only subtle folding abnormalities which lead to the newly synthesized protein being retained at the endoplasmic reticulum by the actions of the cellular quality control system. In this short review article we discuss our recent studies showing that the protein folding defect associated with the most common mutation in patients with cystic fibrosis can be overcome by a novel strategy. As shown in the paper by Brown et al in this issue (Brown et al 1996), a number of different low molecular weight compounds, all known to stabilize proteins in their native conformation, are effective in rescuing the processing defect of the mutant cystic fibrosis transmembrane conductance regulator protein. We then discuss how these same compounds, which we now call chemical chaperones, also may prove to be effective in correcting a number of other protein folding abnormalities which constitute the underlying basis of a large number of different human diseases.
细胞内的蛋白质折叠过程涉及一种被称为分子伴侣的辅助成分的参与。分子伴侣除了积极参与折叠过程外,还充当一种“质量控制系统”,识别、保留错误折叠的蛋白质并将其靶向最终降解。现在已知,许多人类疾病是由于编码必需蛋白质的基因内特定点突变或缺失所致。在许多情况下,这些突变/缺失并不严重到完全破坏特定基因产物的生物学活性。相反,这些突变通常仅导致细微的折叠异常,从而使新合成的蛋白质通过细胞质量控制系统的作用而保留在内质网中。在这篇简短的综述文章中,我们讨论了我们最近的研究,这些研究表明,一种新策略可以克服与囊性纤维化患者最常见突变相关的蛋白质折叠缺陷。正如本期Brown等人的论文(Brown等人,1996年)所示,许多不同的低分子量化合物,已知都能稳定蛋白质的天然构象,它们在挽救突变型囊性纤维化跨膜电导调节蛋白的加工缺陷方面是有效的。然后,我们讨论这些我们现在称为化学伴侣的相同化合物,如何也可能被证明在纠正许多其他构成大量不同人类疾病潜在基础的蛋白质折叠异常方面是有效的。